Molina Healthcare, Inc (NYSE:MOH – Get Free Report) Director Richard Schapiro sold 782 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $203.94, for a total transaction of $159,481.08. Following the completion of the sale, the director owned 11,833 shares of the company’s stock, valued at $2,413,222.02. This trade represents a 6.20% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Molina Healthcare Stock Down 0.2%
MOH traded down $0.48 during trading hours on Friday, hitting $209.37. 362,848 shares of the company’s stock were exchanged, compared to its average volume of 997,807. The firm has a market cap of $10.93 billion, a P/E ratio of -218.09, a price-to-earnings-growth ratio of 12.38 and a beta of 0.75. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $244.89. The firm has a 50 day moving average of $202.56 and a 200 day moving average of $185.69.
Molina Healthcare (NYSE:MOH – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.79 by $0.10. The company had revenue of $11.08 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The firm’s quarterly revenue was down 3.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.84 earnings per share. Analysts predict that Molina Healthcare, Inc will post 5.30 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the company. Wells Fargo & Company decreased their price objective on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating for the company in a report on Tuesday, July 28th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a report on Tuesday, October 27th. Barclays reduced their price target on shares of Molina Healthcare from $180.00 to $178.00 and set an “underweight” rating for the company in a research report on Friday, October 23rd. JPMorgan Chase & Co. increased their price target on shares of Molina Healthcare from $220.00 to $225.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 27th. Finally, Morgan Stanley raised their price objective on shares of Molina Healthcare from $167.00 to $192.00 and gave the stock an “equal weight” rating in a research report on Friday, October 23rd. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $213.88.
Get Our Latest Research Report on MOH
Molina Healthcare News Summary
Investors following MOH have been watching these news items:
- Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
- Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of MOH. Fortitude Family Office LLC boosted its position in shares of Molina Healthcare by 63.7% in the third quarter. Fortitude Family Office LLC now owns 131 shares of the company’s stock worth $25,000 after buying an additional 51 shares during the period. Global Retirement Partners LLC raised its position in Molina Healthcare by 30.4% during the third quarter. Global Retirement Partners LLC now owns 223 shares of the company’s stock valued at $42,000 after buying an additional 52 shares during the period. Allworth Financial LP raised its position in Molina Healthcare by 1.5% during the third quarter. Allworth Financial LP now owns 4,175 shares of the company’s stock valued at $789,000 after buying an additional 60 shares during the period. North Dakota State Investment Board raised its position in Molina Healthcare by 4.2% during the third quarter. North Dakota State Investment Board now owns 1,576 shares of the company’s stock valued at $298,000 after buying an additional 64 shares during the period. Finally, Wedmont Private Capital lifted its stake in Molina Healthcare by 3.6% in the 3rd quarter. Wedmont Private Capital now owns 1,918 shares of the company’s stock worth $375,000 after acquiring an additional 66 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
About Molina Healthcare
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
See Also
- Five stocks we like better than Molina Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
